Tanmay Kulkarni

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Debabrata Mukhopadhyay · 4 shared papers, 2021–2026 · strength 1.06
   • Paper Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extrac… DOI 10.3390/jfb16050160↗
   • Paper Surface Chemistry of Gold Nanoparticles Modulates Cytokines and Nanomechanical Properties in Pancreatic Cancer Cell Lin… DOI 10.26502/fjhs.170↗
   • Paper AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117777↗
2. Santanu Bhattacharya · 3 shared papers, 2021–2025 · strength 0.83
   • Paper Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extrac… DOI 10.3390/jfb16050160↗
   • Paper Surface Chemistry of Gold Nanoparticles Modulates Cytokines and Nanomechanical Properties in Pancreatic Cancer Cell Lin… DOI 10.26502/fjhs.170↗
   • Paper Nanomechanical Insight of Pancreatic Cancer Cell Membrane during Receptor Mediated Endocytosis of Targeted Gold Nanopar… DOI 10.1021/acsabm.0c01443↗
3. Hani M. Babiker · 2 shared papers, 2025–2026 · strength 0.56
   • Paper Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extrac… DOI 10.3390/jfb16050160↗
   • Paper AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117777↗
4. Hari Krishnareddy Rachamala · 1 shared paper, 2026 · strength 0.23
   • Paper AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117777↗
5. Krishnendu Pal · 1 shared paper, 2026 · strength 0.23
   • Paper AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117777↗
6. Naga Malleswara Rao Nakka · 1 shared paper, 2026 · strength 0.23
   • Paper AI-driven discovery and validation of a GIPC1 PDZ domain inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2026.117777↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.